Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 


Print Friendly Page

Protocol No. UW17138

Principal Investigator Kyriakopoulos, Christos

Phase II (Cancer Control)

Age Group Adult

Scope National

Sponsor Type Industry; Institutional

Title Phase II study of Optimized Management of NIVOlumab based on REsponse in patients with advanced renal cell carcinoma (OMNIVORE study)

Applicable Disease Sites Kidney

Drugs Involved BMS-936558 (Nivolumab); Nivolumab; Opdivo (Nivolumab); Yervoy (ipilimumab); ipilimumab

Status Open

Participating Institutions UW Hospital and Clinics